MIST

MILESTONE PHARMACEUTICALS IN

MIST·59935V107·US·Common Stock·Healthcare - Biotechnology-13D/G

MIST (MILESTONE PHARMACEUTICALS IN) is held by 41 institutional investors as of Q2 2026. Largest holders: RTW INVESTMENTS, LP ($10.5M), Point72 Asset Management, L.P. ($7.3M), MILLENNIUM MANAGEMENT LLC ($4.2M). Net institutional sentiment: Mixed.

41
Holders
(6 Elite)
$33.5M
Total Value
35% (37)
Consensus
13 buying - 24 selling
13F: Insider & Congress: Updated regularly
MIST

Smart Money Verdict

View all
Loading verdict
Held by 41 funds
6 elite

Who's Trading

Source dates: Price Aug 28, 2026 · Insiders Apr 20, 2026 · Activists Aug 7, 2026 · Congress none

ActivistPAPavaki Capital Management LLC7.3%Aug 7, 2026
ActivistRTW Investments, LPRTW Investments, LP9.9%May 15, 2026
ActivistADAdage Capital Management, L.P.6.4%May 13, 2026
Checking access…

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
7.8M(+23.7%)$10.5M0.1%-86.44%
34
Increased
5.4M(+398.4%)$7.3M0.0%-17.47%
44
Increased
3.1M(+103.5%)$4.2M0.0%-23.43%
43
Decreased
2M(-12.0%)$2.7M0.0%-36.99%
0
Decreased
1.8M(-7.5%)$2.4M0.0%-38.84%
0
Unchanged
750,000$1M0.0%-47.56%
0
Unchanged
666,666$893,3320.0%-28.48%
0
Decreased
635,211(-12.3%)$851,1830.0%-38.28%
0
Decreased
465,403(-6.0%)$623,6410.0%-38.87%
0
Decreased
359,895(-30.7%)$482,2590.0%-39.40%
0
Increased
339,450(+21.1%)$454,8630.0%-37.22%
29
Decreased
231,824(-31.2%)$310,6440.0%-37.22%
0
Increased
220,873(+14.2%)$295,9700.0%-33.86%
27
Decreased
220,498(-74.1%)$295,4670.0%-28.48%
0
Decreased
173,704(-1.6%)$232,7630.0%-39.80%
0
Increased
140,629(+1223.1%)$188,4430.0%-13.45%
37
Decreased
64,661(-56.6%)$86,6460.0%-28.48%
0
Decreased
57,787(-63.8%)$77,4350.0%-40.44%
0
Decreased
54,171(-63.7%)$72,5890.0%-28.48%
0
Unchanged
40,789$54,6570.0%-55.47%
0

Showing 1-20 of 48

1 / 3
MISTMISTMILESTONE PHARMACEUTICALS IN

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used